Prostemics Co. Ltd (203690) - Total Assets
Based on the latest financial reports, Prostemics Co. Ltd (203690) holds total assets worth ₩39.70 Billion KRW (≈ $26.91 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see 203690 operating cash flow for how efficiently the company converts equity into cash flow.
Prostemics Co. Ltd - Total Assets Trend (2015–2025)
This chart illustrates how Prostemics Co. Ltd's total assets have evolved over time, based on quarterly financial data. See Prostemics Co. Ltd (203690) stock price for real-time trading data and today's change.
Prostemics Co. Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Prostemics Co. Ltd's total assets of ₩39.70 Billion consist of 33.7% current assets and 66.3% non-current assets. Explore Prostemics Co. Ltd short-term liquidity ratio to assess how much short-term liquidity the company maintains relative to its equity base.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 7.6% |
| Accounts Receivable | ₩1.99 Billion | 4.7% |
| Inventory | ₩3.40 Billion | 8.0% |
| Property, Plant & Equipment | ₩0.00 | 0.0% |
| Intangible Assets | ₩54.94 Million | 0.1% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2015–2025)
This chart illustrates how Prostemics Co. Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Prostemics Co. Ltd's current assets represent 33.7% of total assets in 2025, a decrease from 69.2% in 2015.
- Cash Position: Cash and equivalents constituted 7.6% of total assets in 2025, down from 15.4% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2015.
- Asset Diversification: The largest asset category is inventory at 8.0% of total assets.
Prostemics Co. Ltd Competitors by Total Assets
Key competitors of Prostemics Co. Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
argenx NV ADR
NASDAQ:ARGX
|
USA | $10.03 Billion |
|
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL
|
USA | $1.26 Billion |
|
Verona Pharma plc
F:I9SA
|
Germany | €572.87 Million |
|
Tubize-Fin
BR:TUB
|
Belgium | €1.99 Billion |
|
Abivax SA American Depositary Shares
NASDAQ:ABVX
|
USA | $462.21 Million |
|
Ligand Pharmaceuticals Incorporated
NASDAQ:LGND
|
USA | $2.19 Billion |
|
Soleno Therapeutics Inc
NASDAQ:SLNO
|
USA | $608.39 Million |
|
Seegene Inc
KQ:096530
|
Korea | ₩1.27 Trillion |
Prostemics Co. Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.03 | 0.82 | 0.82 |
| Quick Ratio | 0.73 | 0.70 | 0.67 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ₩306.01 Million | ₩-4.94 Billion | ₩-5.73 Billion |
Prostemics Co. Ltd - Advanced Valuation Insights
This section examines the relationship between Prostemics Co. Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.11 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -30.5% |
| Total Assets | ₩42.45 Billion |
| Market Capitalization | $1.88 Million USD |
Valuation Analysis
Below Book Valuation: The market values Prostemics Co. Ltd's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Prostemics Co. Ltd's assets decreased by 30.5% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Prostemics Co. Ltd (2015–2025)
The table below shows the annual total assets of Prostemics Co. Ltd from 2015 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | ₩42.45 Billion ≈ $28.77 Million |
-30.46% |
| 2024-12-31 | ₩61.05 Billion ≈ $41.37 Million |
-20.91% |
| 2023-12-31 | ₩77.19 Billion ≈ $52.31 Million |
+49.94% |
| 2022-12-31 | ₩51.48 Billion ≈ $34.89 Million |
-3.17% |
| 2021-12-31 | ₩53.16 Billion ≈ $36.03 Million |
-11.65% |
| 2020-12-31 | ₩60.18 Billion ≈ $40.78 Million |
+89.00% |
| 2019-12-31 | ₩31.84 Billion ≈ $21.58 Million |
-4.42% |
| 2018-12-31 | ₩33.31 Billion ≈ $22.58 Million |
-17.92% |
| 2017-12-31 | ₩40.58 Billion ≈ $27.50 Million |
-13.76% |
| 2016-12-31 | ₩47.06 Billion ≈ $31.89 Million |
+8.72% |
| 2015-12-31 | ₩43.28 Billion ≈ $29.33 Million |
-- |
About Prostemics Co. Ltd
Ark Solutions Inc. offers hygiene products in South Korea. The company offers wet wipes, adult diapers, and towels. The company also involved in dismantling and recycling vehicles. In addition, it engages in maritime logistics infrastructure business; and cosmetics wholesale and retail business. The company was formerly known as Sphere Power Inc. and changed its name to Ark Solutions Inc. in Nove… Read more